Evidence map›Paper›PMID 39833659›Full record

ArticleThe Journal of clinical endocrinology and metabolism2025

Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes.

Fozia Ahmed, Susanne Hetty, Rutger Laterveer, Ece Busra Surucu, Argyri Mathioudaki, Edvin Hornbrinck, Vagia Patsoukaki, Johan Olausson, Magnus Sundbom, Maria K Svensson and 2 more

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Body mass index and subsequent fracture risk: a meta-analysis to update FRAX.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Metabolic Messengers: oestradiol.Nature metabolism · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Fozia AhmedDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.
Susanne HettyDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.ORCID 0000-0002-0964-6700
Rutger LaterveerDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.
Ece Busra SurucuDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.
Argyri MathioudakiDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.
Edvin HornbrinckDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.
Vagia PatsoukakiDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.
Johan OlaussonDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.
Magnus SundbomDepartment of Surgical Sciences, Uppsala University, 751 85 Uppsala, Sweden.
Maria K SvenssonDepartment of Medical Sciences, Renal Medicine, Uppsala University, 751 85 Uppsala, Sweden.
Maria J PereiraDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.ORCID 0000-0001-5498-3899
Jan W ErikssonDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.ORCID 0000-0002-2639-9481

Funding

Agnes and Mac Rudberg FoundationAstraZeneca R&DEuropean Commission Horizon RIA PAS GRAS 101080329NovoNordisk Foundation NNF20OC0063864NovoNordisk Foundation NNF23OC0084483P.O Zetterlings FoundationSwedish Diabetes Foundation DIA2021-661Swedish National Strategic Research Initiative EXODIAB (Excellence of Diabetes Research in Sweden)Swedish Society for Medical Research (SSMF)the Family Ernfors FoundationUppsala University Hospital ALF
6 · The paper itself

Abstract

contextObesity and insulin resistance in men are linked to decreased testosterone and increased estradiol (E2) levels. Aromatase (ARO) converts testosterone into E2, and this occurs mainly in adipose tissue in men. E2 acts through estrogen receptors ESR1 and ESR2, and they potentially affect development of type 2 diabetes (T2D).

objectiveThis study explored alterations in ARO, ESR1, and ESR2 in men with obesity or T2D.

methodsSubcutaneous adipose tissue (SAT) from men with or without obesity or T2D was analyzed for ARO, ESR1, and ESR2 gene and protein expression. Data were compared across groups and correlated with markers of obesity, glycemia, insulin resistance, and sex hormones. Moreover, SAT was incubated with E2 or testosterone for ex vivo glucose uptake measurements.

resultsARO levels were higher in SAT from men with obesity compared to nonobese men, and gene expression correlated positively with adiposity, hyperglycemia, and insulin resistance. No association was found between ARO and circulating E2. Men with obesity had lower levels of ESR1 and ESR1:ESR2 ratio, but not ESR2. ESR1 gene expression in SAT correlated negatively with adiposity and insulin resistance markers as well as with ARO expression, and tended to be lower in men with T2D. E2 reduced insulin-stimulated glucose uptake, while testosterone increased basal glucose uptake in adipocytes.

conclusionElevated ARO in SAT was found in obese men, and this was linked to insulin resistance and glycemia, supporting the idea that local estrogen production contributes to metabolic dysregulation. ESR1 was reduced in men with T2D and was linked to adiposity and insulin resistance. Taken together, high ARO and altered ESR1:ESR2 balance in SAT in obese men may contribute to insulin resistance and T2D development.

Indexed as

Adipose TissueAromataseDiabetes Mellitus, Type 2Estrogen Receptor alphaEstrogen Receptor betaObesitySubcutaneous FatAdultAgedEstradiolHumansInsulin ResistanceMaleMiddle AgedTestosteroneAromataseESR1 protein, humanESR2 protein, humanEstradiolEstrogen Receptor alphaEstrogen Receptor betaTestosteroneadipose tissuearomataseestradiolestrogen receptorsobesityT2D

Identifiers

PMID39833659
PMCPMC12448628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.